Variant report

Variant	nsv2631
Chromosome Location	chr2:21606995-21652014
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:21645587-21646136	HepG2	liver:	n/a	n/a
2	BHLHE40	chr2:21645735-21646067	HepG2	liver:	n/a	n/a
3	CEBPB	chr2:21619153-21619501	IMR90	lung:	n/a	chr2:21619315-21619326
4	CEBPB	chr2:21619217-21619367	K562	blood:	n/a	chr2:21619315-21619326
5	CEBPB	chr2:21641253-21641776	IMR90	lung:	n/a	chr2:21641255-21641266
6	CEBPB	chr2:21619175-21619449	A549	lung:	n/a	chr2:21619315-21619326
7	CEBPB	chr2:21613134-21613371	HepG2	liver:	n/a	chr2:21613277-21613288
8	CEBPB	chr2:21626353-21626357	A549	lung:	n/a	n/a
9	CEBPB	chr2:21627720-21628029	IMR90	lung:	n/a	n/a
10	CEBPB	chr2:21648839-21648847	HepG2	liver:	n/a	n/a
11	CEBPB	chr2:21641513-21641628	HepG2	liver:	n/a	n/a
12	CEBPB	chr2:21619131-21619520	Hela-S3	cervix:	n/a	chr2:21619315-21619326
13	CEBPB	chr2:21631749-21631776	HepG2	liver:	n/a	chr2:21631758-21631769
14	CEBPB	chr2:21619139-21619505	HepG2	liver:	n/a	chr2:21619315-21619326
15	CEBPB	chr2:21645786-21646035	HepG2	liver:	n/a	n/a
16	CHD2	chr2:21645860-21646000	HepG2	liver:	n/a	n/a
17	CTCF	chr2:21618380-21618530	GM12872	blood:	n/a	chr2:21618429-21618447
18	CTCF	chr2:21638240-21638390	GM06990	blood:	n/a	chr2:21638265-21638278
19	CTCF	chr2:21618337-21618519	GM12891	blood:	n/a	chr2:21618429-21618447
20	CTCF	chr2:21638180-21638330	HBMEC	blood vessel:	n/a	chr2:21638265-21638278
21	CTCF	chr2:21618437-21618464	GM13976	blood:	n/a	n/a
22	CTCF	chr2:21638276-21638383	LNCaP	prostate:	n/a	n/a
23	CTCF	chr2:21618360-21618510	HEK293	kidney:	n/a	chr2:21618429-21618447
24	CTCF	chr2:21618400-21618550	AG04450	lung:	n/a	chr2:21618429-21618447
25	CTCF	chr2:21618020-21618170	WERI-Rb-1	eye:	n/a	n/a
26	CTCF	chr2:21645009-21645244	MCF-7	breast:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
27	CTCF	chr2:21618357-21618540	GM19239	blood:	n/a	chr2:21618429-21618447
28	CTCF	chr2:21618329-21618519	A549	lung:	n/a	chr2:21618429-21618447
29	CTCF	chr2:21618440-21618590	WI-38	lung:	n/a	n/a
30	CTCF	chr2:21645000-21645150	GM12870	blood:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
31	CTCF	chr2:21644981-21645175	SK-N-SH_RA	brain:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
32	CTCF	chr2:21638272-21638387	NHEK	skin:	n/a	n/a
33	CTCF	chr2:21645000-21645150	HMF	breast:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
34	CTCF	chr2:21644996-21645249	GM19238	blood:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
35	CTCF	chr2:21645000-21645150	HCFaa	heart:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
36	CTCF	chr2:21618322-21618493	T-47D	breast:	n/a	chr2:21618429-21618447
37	CTCF	chr2:21645000-21645150	BJ	skin:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
38	CTCF	chr2:21638200-21638350	GM12878	blood:	n/a	chr2:21638265-21638278
39	CTCF	chr2:21618420-21618570	HMEC	breast:	n/a	chr2:21618429-21618447
40	CTCF	chr2:21644987-21645169	SK-N-SH_RA	brain:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
41	CTCF	chr2:21645011-21645249	GM10266	blood:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
42	CTCF	chr2:21620860-21621010	BE2_C	brain:	n/a	n/a
43	CTCF	chr2:21645020-21645170	GM12864	blood:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
44	CTCF	chr2:21638239-21638357	GM19240	blood:	n/a	chr2:21638265-21638278
45	CTCF	chr2:21618320-21618470	GM12869	blood:	n/a	chr2:21618429-21618447
46	CTCF	chr2:21618400-21618550	GM12866	blood:	n/a	chr2:21618429-21618447
47	CTCF	chr2:21645008-21645227	Hela-S3	cervix:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
48	CTCF	chr2:21644968-21645238	MCF-7	breast:	n/a	chr2:21645113-21645131 chr2:21645116-21645129 chr2:21645115-21645136 chr2:21645114-21645130
49	CTCF	chr2:21638086-21638491	MCF-7	breast:	n/a	chr2:21638265-21638278
50	CTCF	chr2:21638200-21638350	Caco-2	colon:	n/a	chr2:21638265-21638278

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:21646627-21646677	Hela-S3	cervix:	n/a
2	chr2:21646627-21646677	ECC-1	luminal epithelium:	n/a
3	chr2:21646627-21646677	HCF	heart:	n/a
4	chr2:21646627-21646677	AoSMC	blood vessel:	n/a
5	chr2:21646627-21646677	BE2_C	brain:	n/a
6	chr2:21646627-21646677	HRE	kidney:	n/a
7	chr2:21646627-21646677	H1-hESC	embryonic stem cell:	embryo
8	chr2:21646627-21646677	LNCaP	prostate:	n/a
9	chr2:21646627-21646677	NB4	blood:	n/a
10	chr2:21646627-21646677	BJ	skin:	n/a
11	chr2:21646627-21646677	Hepatocyte	liver:	n/a
12	chr2:21646627-21646677	NHDF-neo	bronchial:	n/a
13	chr2:21646627-21646677	ProgFib	skin:	n/a
14	chr2:21646627-21646677	HAEpiC	amniotic membrane:	n/a
15	chr2:21646627-21646677	Caco-2	colon:	n/a
16	chr2:21646627-21646677	HCT-116	colon:	n/a
17	chr2:21646627-21646677	PrEC	prostate:	n/a
18	chr2:21646627-21646677	T-47D	breast:	n/a
19	chr2:21646627-21646677	HCM	heart:	n/a
20	chr2:21646627-21646677	U87	brain:	n/a
21	chr2:21646627-21646677	GM12878	blood:	n/a
22	chr2:21646627-21646677	HMEC	breast:	n/a
23	chr2:21646627-21646677	GM19239	blood:	n/a
24	chr2:21646627-21646677	IMR90	lung:	fetal
25	chr2:21646627-21646677	NH-A	brain:	n/a
26	chr2:21646627-21646677	MCF10A-Er-Src	breast:	n/a
27	chr2:21646627-21646677	Jurkat	blood:	n/a
28	chr2:21646627-21646677	NHBE	bronchial:	n/a
29	chr2:21646627-21646677	HIPEpiC	eye:	n/a
30	chr2:21646627-21646677	HNPCEpiC	eye:	n/a
31	chr2:21646627-21646677	HEK293	kidney:	embryo
32	chr2:21646627-21646677	ovcar-3	ovarian:	n/a
33	chr2:21646627-21646677	HRPEpiC	eye:	n/a
34	chr2:21646627-21646677	RPTEC	kidney:	n/a
35	chr2:21646627-21646677	HUVEC	blood vessel:	n/a
36	chr2:21646627-21646677	HRCEpiC	kidney:	n/a
37	chr2:21646627-21646677	AG04450	lung:	fetal
38	chr2:21646627-21646677	GM12891	blood:	n/a
39	chr2:21646627-21646677	HPAEpiC	pulmonary alveolar:	n/a
40	chr2:21646627-21646677	PANC-1	pancreas:	n/a
41	chr2:21646627-21646677	AG10803	skin:	n/a
42	chr2:21646627-21646677	GM06990	blood:	n/a
43	chr2:21646627-21646677	HEEpiC	esophagus:	n/a
44	chr2:21646627-21646677	SK-N-MC	brain:	n/a
45	chr2:21646627-21646677	AG04449	skin:	fetal
46	chr2:21646627-21646677	GM12892	blood:	n/a
47	chr2:21646627-21646677	MCF-7	breast:	n/a
48	chr2:21646627-21646677	CMK	blood:	n/a
49	chr2:21646627-21646677	AG09319	gingival:	n/a
50	chr2:21646627-21646677	K562	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:21612257..21615069-chr2:21615594..21618412,3	MCF-7	breast:
2	chr2:21609330..21611613-chr2:21622342..21624204,2	K562	blood:
3	chr2:21612257..21615069-chr2:21615594..21618412,3	MCF-7	breast:
4	chr2:21625273..21627610-chr2:21631659..21634157,2	MCF-7	breast:
5	chr2:21625273..21627610-chr2:21631659..21634157,2	MCF-7	breast:
6	chr2:21595342..21596346-chr2:21617977..21618695,3	MCF-7	breast:
7	chr2:21609330..21611613-chr2:21622342..21624204,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC010872.2.1-3	chr2:21619354-21619756	NONHSAT069493
2	lnc-AC010872.2.1-3	chr2:21619455-21619756	ENSG00000231204
3	lnc-AC010872.2.1-3	chr2:21625767-21626046	ENSG00000231204
4	lnc-AC010872.2.1-3	chr2:21618893-21619046	ENSG00000231204
5	lnc-AC010872.2.1-3	chr2:21618948-21619046	ENSG00000231204
6	lnc-AC010872.2.1-3	chr2:21625767-21626032	NONHSAT069493
7	lnc-AC010872.2.1-3	chr2:21625767-21626046	ENSG00000231204
8	lnc-AC010872.2.1-8	chr2:21637670-21637690	NONHSAT069484
9	lnc-AC010872.2.1-8	chr2:21636249-21636321	NONHSAT069484

Variant related genes	Relation type
ENSG00000231204	TF binding region
ENSG00000231204	CpG island

Extended variants
information (count: 1605 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:1605 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185226358	chr2:21607022-21607023	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs553378917	chr2:21607029-21607030	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs541140052	chr2:21607038-21607039	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs545618887	chr2:21607075-21607076	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs7608111	chr2:21607079-21607080	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs559901731	chr2:21607086-21607087	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs150448662	chr2:21607112-21607113	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs75418329	chr2:21607126-21607127	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs145417088	chr2:21607129-21607130	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs575039510	chr2:21607143-21607144	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs141388263	chr2:21607145-21607146	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs566919854	chr2:21607191-21607192	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs540612457	chr2:21607230-21607231	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs532631931	chr2:21607250-21607251	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs144991951	chr2:21607331-21607332	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs568986909	chr2:21607390-21607391	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs537667022	chr2:21607465-21607466	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs138839402	chr2:21607493-21607494	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs140498574	chr2:21607507-21607508	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs533880405	chr2:21607523-21607524	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs113614131	chr2:21607548-21607549	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs571966680	chr2:21607566-21607567	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs553341874	chr2:21607576-21607577	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs112877844	chr2:21607579-21607580	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs539471637	chr2:21607584-21607585	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs190914114	chr2:21607587-21607588	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs575756962	chr2:21607611-21607612	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs544466092	chr2:21607660-21607661	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs561497751	chr2:21607680-21607681	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs575208756	chr2:21607690-21607691	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs530327662	chr2:21607700-21607701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs540969656	chr2:21607741-21607742	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs542397236	chr2:21607748-21607749	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs141268795	chr2:21607763-21607764	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs532406585	chr2:21607770-21607771	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs552613644	chr2:21607788-21607789	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs562857325	chr2:21607829-21607830	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs531860887	chr2:21607869-21607870	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs150762408	chr2:21607881-21607882	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs567953874	chr2:21607889-21607890	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs533795513	chr2:21607905-21607906	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs7603669	chr2:21607928-21607929	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs570397510	chr2:21607934-21607935	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs539075692	chr2:21607935-21607936	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs556155078	chr2:21608023-21608024	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs571185250	chr2:21608035-21608036	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs576037137	chr2:21608048-21608049	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs535594547	chr2:21608105-21608106	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs7606598	chr2:21608110-21608111	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs575096876	chr2:21608130-21608131	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	21508638	CNVD
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Ependymoma	16718352	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	20607354	CNVD
Neuroblastoma	19638189	CNVD
Neuroblastoma	19435921	CNVD
Neuroblastoma	18574593	CNVD
Acute myeloid leukemia	18000384	CNVD
Medulloblastoma	16968546	CNVD
Medulloblastoma	22160402	CNVD
Schizophrenia	22118685	CNVD
Epilepsy	22118685	CNVD
Breast cancer	21509527	CNVD
Leukemia	18628472	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Ovarian cancer	17908972	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	18765546	CNVD
Neuroblastoma	18281664	CNVD
Neuroblastoma	17289879	CNVD
Neuroblastoma	19738985	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:70 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:21582000-21634600	Weak transcription	Aorta	Aorta
2	chr2:21597400-21611200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr2:21603800-21607000	Enhancers	Brain Germinal Matrix	brain
4	chr2:21603800-21607400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
5	chr2:21605000-21607000	Enhancers	Cortex derived primary cultured neurospheres	brain
6	chr2:21605000-21607000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
7	chr2:21606600-21607800	Enhancers	Ovary	ovary
8	chr2:21606800-21607000	Enhancers	Brain Cingulate Gyrus	brain
9	chr2:21607400-21607600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
10	chr2:21611200-21611800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr2:21611400-21611600	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr2:21611400-21611600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr2:21611400-21611600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
14	chr2:21611600-21612800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr2:21613000-21613600	Enhancers	Fetal Brain Male	brain
16	chr2:21614000-21615600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
17	chr2:21615400-21616200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr2:21615400-21616800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
19	chr2:21615600-21616000	Enhancers	Brain Germinal Matrix	brain
20	chr2:21615600-21616400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr2:21615800-21616200	Enhancers	Placenta Amnion	Placenta Amnion
22	chr2:21616000-21616600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
23	chr2:21616200-21618800	Weak transcription	Placenta Amnion	Placenta Amnion
24	chr2:21618600-21619200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr2:21618800-21619000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr2:21618800-21619200	Enhancers	Placenta Amnion	Placenta Amnion
27	chr2:21627200-21628000	Enhancers	HUES6 Cell Line	embryonic stem cell
28	chr2:21627200-21628400	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr2:21627400-21628000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
30	chr2:21627400-21628000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
31	chr2:21627400-21628200	Enhancers	HUES64 Cell Line	embryonic stem cell
32	chr2:21627800-21628200	Enhancers	HUES48 Cell Line	embryonic stem cell
33	chr2:21627800-21628400	Enhancers	H1 Cell Line	embryonic stem cell
34	chr2:21627800-21628400	Enhancers	iPS-15b Cell Line	embryonic stem cell
35	chr2:21628400-21635600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
36	chr2:21629000-21631600	Enhancers	Fetal Muscle Leg	muscle
37	chr2:21634600-21636600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr2:21634800-21635200	Bivalent Enhancer	HepG2	liver
39	chr2:21635000-21635200	Enhancers	Fetal Stomach	stomach
40	chr2:21635600-21636000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr2:21635600-21636400	Enhancers	ES-I3 Cell Line	embryonic stem cell
42	chr2:21635600-21636400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
43	chr2:21635800-21636000	Enhancers	Fetal Stomach	stomach
44	chr2:21636600-21638200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr2:21638200-21640000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
46	chr2:21640000-21640400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr2:21640000-21640800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr2:21640400-21641000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
49	chr2:21640400-21641000	Enhancers	Breast Myoepithelial Primary Cells	Breast
50	chr2:21641000-21641600	Enhancers	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links